Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 360 entries
View as:

Magnetic Resonance Imaging to Evaluate Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00182624 Org: User:
Start: 02/02/04 End: 09/06/07 Due: 09/06/08

Study of Tongue Pressures

Phase: N/A Priority: Normal
NCT ID: NCT00013832 Org: User:
Start: 03/28/01 End: 04/11/07 Due: 04/11/08

Effects of Bronchial Segmental Endotoxin Instillation in Humans

Phase: N/A Priority: Normal
NCT ID: NCT02392442 Org: User:
Start: 06/18/15 End: 06/30/27 Due: 06/30/28

Heart Disease in Sickle Cell Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00113152 Org: User:
Start: 06/02/05 End: 10/02/07 Due: 10/02/08

Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV

Phase: N/A Priority: Normal
NCT ID: NCT02124044 Org: User:
Start: 02/28/14 End: 11/30/16 Due: 11/30/17

MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00064909 Org: User:
Start: 07/31/03 End: 03/31/06 Due: 03/31/07

17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00088868 Org: User:
Start: 06/30/04 End: 12/31/10 Due: 12/31/11

Evaluation of Atherosclerotic Plaques in Abdominal CT Studies

Phase: N/A Priority: Normal
NCT ID: NCT04652973 Org: User:
Start: 11/19/20 End: 08/30/30 Due: 08/30/31

Dopamine and Motor Learning in Cerebral Palsy

Phase: N/A Priority: Normal
NCT ID: NCT02839733 Org: User:
Start: 06/21/17 End: 11/12/24 Due: 11/12/25

Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

Phase: N/A Priority: Normal
NCT ID: NCT04258566 Org: User:
Start: 01/27/22 End: 01/29/25 Due: 01/29/26

Testing Devices That Involve the Sense of Touch in Subjects With Traumatic Brain Injury

Phase: N/A Priority: Normal
NCT ID: NCT01404494 Org: User:
Start: 04/05/11 End: 02/06/15 Due: 02/06/16

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00020579 Org: User:
Start: 03/31/01 End: 10/31/08 Due: 10/31/09

Evaluation of MiSeq for Microbial Identification in Specimens

Phase: N/A Priority: Normal
NCT ID: NCT02578875 Org: User:
Start: 11/12/15 End: 09/30/19 Due: 09/30/20

Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products

Phase: N/A Priority: Normal
NCT ID: NCT02056613 Org: User:
Start: 02/05/14 End: 11/01/18 Due: 11/01/19

Evaluating Supportive Care for Children With Cancer: A Multi-Institutional Survey Study of Pediatric Oncology Patients and Parents

Phase: N/A Priority: Normal
NCT ID: NCT01273194 Org: User:
Start: 12/20/10 End: 09/08/15 Due: 09/08/16

Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples

Phase: N/A Priority: Normal
NCT ID: NCT01597089 Org: User:
Start: 09/01/12 End: 05/01/18 Due: 05/01/19

Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT04698382 Org: User:
Start: 08/01/20 End: 12/31/23 Due: 12/31/24

Detection of Coronary Artery Calcification: Comparison of Volumetric and Electron Beam Computed Tomography

Phase: N/A Priority: Normal
NCT ID: NCT00001836 Org: User:
Start: 10/31/98 End: 11/30/01 Due: 11/30/02

Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin

Phase: N/A Priority: Normal
NCT ID: NCT00066664 Org: User:
Start: 06/30/03 End: 03/31/10 Due: 03/31/11

Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00075348 Org: User:
Start: 12/31/03 End: 12/31/08 Due: 12/31/09

Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00096382 Org: User:
Start: 09/30/04 End: 01/31/09 Due: 01/31/10

The Early Reversibility of Rocuronium After Different Doses of Neostigmine

Phase: N/A Priority: Normal
NCT ID: NCT00001520 Org: User:
Start: 09/30/96 End: 08/31/00 Due: 08/31/01

Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes

Phase: N/A Priority: Normal
NCT ID: NCT01236573 Org: User:
Start: 10/31/10 End: 03/31/15 Due: 03/31/16

Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00083057 Org: User:
Start: 05/31/04 End: 11/30/10 Due: 11/30/11

Study of Hair Samples From Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00899691 Org: User:
Start: 03/31/05 End: 10/31/08 Due: 10/31/09